Wave Life Sciences Posts $61.9 Million Q3 Loss, Beats Analyst Estimates on Revenue

Wave Life Sciences Pte. Ltd. (WVE) reported a loss of $61.9 million, or 30 cents per share, for its third quarter on Tuesday, exceeding Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 34 cents per share. The Singapore-based biopharmaceutical company posted revenue of $13.2 million for the period, well above the $3 million forecast by four Zacks analysts. The company's quarterly results surpassed consensus on both earnings and revenue.